Structure
Rosiglitazone is a TZD with a similar core structure to pioglitazone but contains a different aromatic substituent, enhancing its potency.
Chemical Formula: C₁₉H₂₅N₃O₃S


Mode of Action
PPAR-γ Agonism: Increases insulin sensitivity in peripheral tissues.
Anti-Inflammatory Effects: Reduces inflammatory markers associated with insulin resistance.
Uses
Type 2 Diabetes Mellitus: Enhances insulin sensitivity to improve glycemic control.
Metabolic Syndrome: Assists in managing insulin resistance and dyslipidemia.
Note
Cardiovascular Risks: Associated with increased risk of myocardial infarction; usage restricted or monitored closely in many regions.